105 related articles for article (PubMed ID: 34051687)
1. Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study.
Michalopoulou E; Matthes KL; Karavasiloglou N; Wanner M; Limam M; Korol D; Held L; Rohrmann S
Cancer Epidemiol; 2021 Aug; 73():101962. PubMed ID: 34051687
[TBL] [Abstract][Full Text] [Related]
2. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis.
Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
[TBL] [Abstract][Full Text] [Related]
3. Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.
Limam M; Matthes KL; Pestoni G; Michalopoulou E; Held L; Dehler S; Korol D; Rohrmann S
J Cancer Res Clin Oncol; 2021 May; 147(5):1407-1419. PubMed ID: 33661394
[TBL] [Abstract][Full Text] [Related]
4. It's contrary - comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort.
Bouter C; Bebington B; Maphosa S; Maher H; Gaylard P; Etheredge HR; Fabian J; Prodehl L; Surridge D; Fourie RL; Harran N; Lutrin D; Bizos D; Ruff P
S Afr Med J; 2020 Apr; 110(5):382-388. PubMed ID: 32657722
[TBL] [Abstract][Full Text] [Related]
5. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
[TBL] [Abstract][Full Text] [Related]
6. The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study.
Cuthbert CA; Hemmelgarn BR; Xu Y; Cheung WY
J Cancer Surviv; 2018 Dec; 12(6):733-743. PubMed ID: 30191524
[TBL] [Abstract][Full Text] [Related]
7. The effects of comorbidity on colorectal cancer mortality in an Australian cancer population.
Pule ML; Buckley E; Niyonsenga T; Roder D
Sci Rep; 2019 Jun; 9(1):8580. PubMed ID: 31189947
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study.
Villavicencio A; Solans M; Zacarías-Pons L; Vidal A; Puigdemont M; Roncero JM; Saez M; Marcos-Gragera R
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467494
[TBL] [Abstract][Full Text] [Related]
9. Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study.
Erichsen R; Horváth-Puhó E; Iversen LH; Lash TL; Sørensen HT
Br J Cancer; 2013 Oct; 109(7):2005-13. PubMed ID: 24022185
[TBL] [Abstract][Full Text] [Related]
10. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.
Tong L; Ahn C; Symanski E; Lai D; Du XL
Ann Oncol; 2014 Jun; 25(6):1234-42. PubMed ID: 24681607
[TBL] [Abstract][Full Text] [Related]
11. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
12. Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study.
Samawi HH; Yin Y; Speers CH; Cheung WY
Clin Colorectal Cancer; 2018 Dec; 17(4):e711-e717. PubMed ID: 30120076
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis.
Boakye D; Rillmann B; Walter V; Jansen L; Hoffmeister M; Brenner H
Cancer Treat Rev; 2018 Mar; 64():30-39. PubMed ID: 29459248
[TBL] [Abstract][Full Text] [Related]
14. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
15. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer.
Hahn EE; Gould MK; Munoz-Plaza CE; Lee JS; Parry C; Shen E
J Natl Compr Canc Netw; 2018 Jan; 16(1):23-34. PubMed ID: 29295878
[No Abstract] [Full Text] [Related]
16. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
[TBL] [Abstract][Full Text] [Related]
17. Correcting bias due to missing stage data in the non-parametric estimation of stage-specific net survival for colorectal cancer using multiple imputation.
Falcaro M; Carpenter JR
Cancer Epidemiol; 2017 Jun; 48():16-21. PubMed ID: 28315607
[TBL] [Abstract][Full Text] [Related]
18. Estimating excess hazard ratios and net survival when covariate data are missing: strategies for multiple imputation.
Falcaro M; Nur U; Rachet B; Carpenter JR
Epidemiology; 2015 May; 26(3):421-8. PubMed ID: 25774607
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the measurement of comorbidity for a South Australian colorectal cancer population using administrative data.
Pule L; Buckley E; Niyonsenga T; Roder D
J Eval Clin Pract; 2020 Aug; 26(4):1250-1258. PubMed ID: 31721394
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).
Wong ML; McMurry TL; Schumacher JR; Hu CY; Stukenborg GJ; Francescatti AB; Greenberg CC; Chang GJ; McKellar DP; Walter LC; Kozower BD
J Oncol Pract; 2018 Oct; 14(10):e631-e643. PubMed ID: 30207852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]